Table 1.
Summary of studies investigated links between gut microbiota and intestinal diseases
Increase | Decrease | Pathological features | |
---|---|---|---|
IBD | Proteobacteria | Firmicutes | Disruption of intestinal barrier |
Intestinal mucosal inflammation | |||
Bacterial antigen translocation increased | |||
PI-IBD | Escherichia, Veillonella, Megasphera and Lachnospiraceae | Prevotella | Bacterial adhesion |
Roseburia bacteroidetes Lactobacillus | Inflammatory autoimmune disease | ||
IBS | Methane bacteria | Lactobacillus | Gastrointestinal infections |
Bifidobacterium | Intestinal bacterial overgrowth (SIBO) | ||
Coliform and pathogen translocation increased | |||
Chronic constipation | Bacteroides | Firmicutes, Clostridium, Lactobacillus, Desulfovibrio, and Methylobacterium | Intestinal SERT |
Akkermansia muciniphila Bacteroides | Decrease the level of 5-HT | ||
Osmotic diarrhea | Bacteroides | S24-7 bacteria | Changes in intestinal osmotic pressure |
Y deformation bacteria | |||
CRC | Fusobacterium nucleatum, P. anaerobius, Peptostreptococcus stomatis, Solobacterium moorei, Gemella morbillorum and Parvimonas micra | Transform the microbiome | |
Create a tumour environment | |||
Tumour cell proliferation | |||
The inflammatory response |